Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tomassini

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
La Radiologia Medica|October 1, 1988
[Gynecologic intracavity brachytherapy of a high-dose intensity. A review of the literature]F Bistolfi, S Papadia, G Scielzo, et al.
La Radiologia Medica|October 1, 1989
[High-dose gynecologic endocavitary brachytherapy. Technical and dosimetric aspects]F Grillo Ruggieri, E Parietti, F Bistolfi, et al.
Diabetes, Obesity & Metabolism|June 11, 2009
Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemiaJ E Tomassini, T Mazzone, R B Goldberg, et al.
Panminerva Medica|July 1, 1988
Hodgkin's disease. Results of treatment in early stagesV Vitale, G Scielzo, G Ricci, et al.
Diabetes Care|February 13, 2010
Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemiaRonald B Goldberg, John R Guyton, Theodore Mazzone, et al.
The American Journal of Cardiology|November 26, 2008
Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart diseaseScott E Conard, Harold E Bays, Lawrence A Leiter, et al.
Journal of Clinical Lipidology|February 5, 2011
Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetesRuth S Weinstock, Ronald B Goldberg, John R Guyton, et al.
Journal of Clinical Lipidology|December 3, 2010
Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patientsKaan Tunceli, Shiva G Sajjan, Dena R Ramey, et al.
Vascular Health and Risk Management|November 23, 2013
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapyJoAnne M Foody, Peter P Toth, Joanne E Tomassini, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|May 1, 1993
[The multidisciplinary treatment of rhabdomyosarcoma in childhood. A 10-year multicenter experience (1978-1988) in Liguria]M L Vitali, G Ricci, A Acquaviva, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
La Radiologia Medica|October 1, 1988
[Gynecologic intracavity brachytherapy of a high-dose intensity. A review of the literature]F Bistolfi, S Papadia, G Scielzo, et al.
La Radiologia Medica|October 1, 1989
[High-dose gynecologic endocavitary brachytherapy. Technical and dosimetric aspects]F Grillo Ruggieri, E Parietti, F Bistolfi, et al.
Diabetes, Obesity & Metabolism|June 11, 2009
Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemiaJ E Tomassini, T Mazzone, R B Goldberg, et al.
Panminerva Medica|July 1, 1988
Hodgkin's disease. Results of treatment in early stagesV Vitale, G Scielzo, G Ricci, et al.
Diabetes Care|February 13, 2010
Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemiaRonald B Goldberg, John R Guyton, Theodore Mazzone, et al.
The American Journal of Cardiology|November 26, 2008
Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart diseaseScott E Conard, Harold E Bays, Lawrence A Leiter, et al.
Journal of Clinical Lipidology|February 5, 2011
Effect of ezetimibe/simvastatin vs atorvastatin on lowering levels of LDL-C and non-HDL-C, ApoB, and hs-CRP in patients with type 2 diabetesRuth S Weinstock, Ronald B Goldberg, John R Guyton, et al.
Journal of Clinical Lipidology|December 3, 2010
Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patientsKaan Tunceli, Shiva G Sajjan, Dena R Ramey, et al.
Vascular Health and Risk Management|November 23, 2013
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapyJoAnne M Foody, Peter P Toth, Joanne E Tomassini, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|May 1, 1993
[The multidisciplinary treatment of rhabdomyosarcoma in childhood. A 10-year multicenter experience (1978-1988) in Liguria]M L Vitali, G Ricci, A Acquaviva, et al.
Pageof 12